Travere Therapeutics to Report Third Quarter 2024 Financial Results

SAN DIEGO , Oct. 21, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2024 financial results on Thursday, October 31, 2024 , before the open of the U.S. financial markets. The Company will host a conference call and webcast to discuss

View Full Press Release
Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024